Breast Cancer in Canadian Women

被引:1
作者
Heather Bryant
机构
[1] Division of Population Health and Information, Alberta Cancer Board, Calgary
基金
英国医学研究理事会;
关键词
Breast Cancer; Breast Cancer Risk; Mammographic Screening; Raloxifene; Tamoxifen;
D O I
10.1186/1472-6874-4-S1-S12
中图分类号
学科分类号
摘要
Health issue: Although lung cancer is the leading cause of cancer deaths for Canadian women, breast cancer is the most frequently diagnosed. About 5400 women are expected to die from this disease in 2003. In 1998, a woman's lifetime risk of breast cancer was about one in nine. Key findings: A number of risk factors for breast cancer have been identified. These include advancing age, hormonal factors (eg. early menarche, late menopause and late age at first full-term pregnancy), familial risk, BRCA-1 and BRCA-2 gene mutations, diet and postmenopausal obesity. Several interventions have been introduced to assist women at high risk for breast cancer, including genetic counseling and testing for women who have strong family histories of breast cancer; selective estrogen receptor modifiers, such as tamoxifen, that has been shown to reduce breast cancer rates; prophylactic mastectomy and screening. Data gaps and recommendations: Guidelines are unclear in several areas, particularly in screening. Where clinical guidelines are available, health services research or ongoing monitoring (by provincial/territorial cancer agencies) is needed to assess compliance with the guidelines and to ensure equity of access within the provinces/territories. Key components of organized screening programs need to be established, in part to ensure that screening is carried out in high-quality, co-ordinated programs. There is also a need to develop ways to involve women fully in informed decision-making and to address several policy issues to prevent disparities in access to high-quality services. Patenting issues associated with genetic tests also need to be clarified. © Bryant; licensee BioMed Central Ltd 2004. This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
引用
收藏
相关论文
共 55 条
[1]  
Report on the National Forum on Breast Cancer, (1994)
[2]  
Canadian cancer statistics 2002, (2002)
[3]  
Gaudette L.A., Silberberger C., Altmayer C.A., Gao R., Trends in breast cancer incidence and mortality, Health Rep, 8, pp. 29-38, (1996)
[4]  
Gaudette L.A., Altmayer C.A., Nobrega K.M.P., Lee J., Trends in mammography utilization, 1981–1994, Health Rep, 8, pp. 17-28, (1996)
[5]  
Mammograms and breast examinations, In: Statistical report on the health of Canadians, pp. 82-86, (1999)
[6]  
Bryant H.E., Brasher P.M.A., Risks and probabilities of breast cancer: short-term versus lifetime probabilities, Can Med Assoc J, 150, pp. 211-216, (1994)
[7]  
Wilkins K., Causes of death: how the sexes differ, Health Rep, 7, pp. 33-44, (1995)
[8]  
Bryant H., Murphy E., Fayers C., Argyle N., A snapshot of cancer in Alberta, (2001)
[9]  
Reynolds T., Declining breast cancer mortality: What's behind it?, J Natl Cancer Inst, 91, pp. 750-753, (1999)
[10]  
Ellison L.F., Gibbons L., Five year relative survival from prostate, breast, colorectal and lung cancer, Health Rep, 13, pp. 23-34, (2001)